Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

Bibliographic Details
Main Authors: Jihye Park, Jae Hee Cheon
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2017-07-01
Series:Intestinal Research
Online Access:https://doi.org/10.5217/ir.2017.15.3.263
id doaj-45e2099c0a194d0bbe4e41caa70ae9cc
record_format Article
spelling doaj-45e2099c0a194d0bbe4e41caa70ae9cc2020-11-24T23:20:35ZengKorean Association for the Study of Intestinal DiseasesIntestinal Research1598-91002017-07-0115326326510.5217/ir.2017.15.3.263ir.2017.15.3.263Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?Jihye Park0Jae Hee Cheon1Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.https://doi.org/10.5217/ir.2017.15.3.263
collection DOAJ
language English
format Article
sources DOAJ
author Jihye Park
Jae Hee Cheon
spellingShingle Jihye Park
Jae Hee Cheon
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
Intestinal Research
author_facet Jihye Park
Jae Hee Cheon
author_sort Jihye Park
title Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
title_short Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
title_full Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
title_fullStr Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
title_full_unstemmed Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?
title_sort could adalimumab be used safely and effectively in intestinal behçet's disease refractory to conventional therapy?
publisher Korean Association for the Study of Intestinal Diseases
series Intestinal Research
issn 1598-9100
publishDate 2017-07-01
url https://doi.org/10.5217/ir.2017.15.3.263
work_keys_str_mv AT jihyepark couldadalimumabbeusedsafelyandeffectivelyinintestinalbehcetsdiseaserefractorytoconventionaltherapy
AT jaeheecheon couldadalimumabbeusedsafelyandeffectivelyinintestinalbehcetsdiseaserefractorytoconventionaltherapy
_version_ 1725574430103437312

Similar Items